Browse studies, page 1118

Page 1118 of 1,159, newest first. Search them all at once, ranked by relevance, in Evidence Hub.

• Remote Ischemic Conditioning in the Prevention for Stroke-Associated Pneumonia: A Pilot Randomized Controlled Trial Frontiers in Neurology, 2022
• Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial Trials, 2021
• Convalescent plasma in the treatment of moderate to severe COVID-19 pneumonia: a randomized controlled trial (PROTECT-Patient Trial) Scientific Reports, 2022
• Efficacy and safety of low-molecular-weight collagen peptides in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial Frontiers in Nutrition, 2025
• Clinical Efficacy Protocol of Yinhuapinggan Granules: A Randomized, Double-Blind, Parallel, and Controlled Clinical Trial Program for the Intervention of Community-Acquired Drug-Resistant Bacterial Pneumonia as a Complementary Therapy Frontiers in Pharmacology, 2022
• Efficacy and Safety of LY3127804, an Anti-Angiopoietin-2 Antibody, in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial in Patients Hospitalized with Pneumonia and Presumed or Confirmed COVID-19 Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, 2022
• Efficacy and safety of Lianhua Qingwen granule in the treatment of non-influenza viral pneumonia: a randomized, double-blind, placebo-controlled, multicenter clinical study Frontiers in Medicine, 2024
• Efficacy and safety of a Chinese herbal formula Maxing Ganshi Decoction in children with community-acquired pneumonia: A randomized, double-blind, placebo-controlled, multicenter trial Frontiers in Pharmacology, 2022
• Safety and efficacy of favipiravir in COVID-19 patients with pneumonia. A randomized, double-blind, placebo-controlled study (FAVID) Pneumonia, 2024
• Efficacy of continuous versus intermittent subglottic secretion drainage in preventing ventilator-associated pneumonia in patients requiring mechanical ventilation: A single-center randomized controlled trial OncoTarget, 2018
• Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for COVID-19 Pneumonia: A Randomized Clinical Trial Clinical Infectious Diseases, 2024
• A randomized controlled non-inferiority trial of placebo versus macrolide antibiotics for Mycoplasma pneumoniae infection in children with community-acquired pneumonia: trial protocol for the MYTHIC Study Trials, 2024
• Efficacy of Adjunctive Zinc in Improving the Treatment Outcomes in Hospitalized Children with Pneumonia: A Randomized Controlled Trial Journal of Tropical Pediatrics, 2019
• Yinma Jiedu granules combined with antibacterial drugs for patients with community-acquired pneumonia: protocol for a multicenter, randomized, double-blind, placebo-parallel controlled clinical trial Frontiers in Medicine, 2025
• Efficacy and safety of aerosol inhalation of recombinant human interferon α1b (IFNα1b) injection for noninfluenza viral pneumonia, a multicenter, randomized, double-blind, placebo-controlled trial Journal of Inflammation, 2020
• Respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in severe SARS-CoV-2 pneumonia: a multicentre randomized controlled trial Clinical Microbiology and Infection, 2023
• Efficacy of anakinra in reducing progression to organ dysfunction in patients with pneumonia (INSPIRE): a randomised, double-blind, placebo-controlled, phase IIa trial The Lancet Regional Health - Europe, 2025
• A Prospective phase IIA Multicenter Double-Blinded Randomized Placebo-Controlled Clinical Trial Evaluating the Efficacy and Safety of Inhaled Tobramycin in Patients with Ventilator-Associated Pneumonia (iToVAP) Anaesthesia Critical Care & Pain Medicine, 2023
• A randomized, controlled, multicenter clinical trial to evaluate the efficacy and safety of oral sitafloxacin versus moxifloxacin in adult patients with community-acquired pneumonia Current Medical Research and Opinion, 2021
• Efficacy of an Herbal Preparation (Atomy’s HemoHIM®) against Ventilator-associated Pneumonia: A Randomized Controlled Clinical Trial Journal of Research in Pharmacy Practice, 2023
• Comparison of Efficacy and Safety Profiles Between Omadacycline and Moxifloxacin in Elderly Patients with Community‐Acquired Pneumonia: A Randomized, Controlled Trial Clinical pharmacology in drug development, 2025
• Efficacy and safety of anemoside B4 in canine pneumonia treatment: a prospective, randomized controlled trial Frontiers in Veterinary Science, 2025
• Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial Critical care (London, England), 2011
• The Impact of an Antimicrobial Utilization Program on Antimicrobial Use at a Large Teaching Hospital: A Randomized Controlled Trial Infection control and hospital epidemiology, 2009
• Exposure to ceftobiprole is associated with microbiological eradication and clinical cure in patients with nosocomial pneumonia Antimicrobial agents and chemotherapy, 2014
• Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial Lancet (London, England), 2020
• Fosfomycin for Injection (ZTI-01) Versus Piperacillin-tazobactam for the Treatment of Complicated Urinary Tract Infection Including Acute Pyelonephritis: ZEUS, A Phase 2/3 Randomized Trial Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019
• Effects of probenecid and cimetidine on the pharmacokinetics of nemonoxacin in healthy Chinese volunteers Drug design, development and therapy, 2016
• Xuebijing injection in the treatment of severe pneumonia: study protocol for a randomized controlled trial Trials, 2016
• High-dose versus standard-dose amoxicillin/clavulanate for clinically-diagnosed acute bacterial sinusitis: A randomized clinical trial PloS one, 2018
• Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial PloS one, 2017
• Zabofloxacin versus moxifloxacin in patients with COPD exacerbation: a multicenter, double-blind, double-dummy, randomized, controlled, Phase III, non-inferiority trial International journal of chronic obstructive pulmonary disease, 2015
• Pharmacokinetics and Safety of Intravenous Murepavadin Infusion in Healthy Adult Subjects Administered Single and Multiple Ascending Doses Antimicrobial agents and chemotherapy, 2018
• Glasdegib plus low-dose cytarabine for acute myeloid leukemia: Practical considerations from advanced practitioners and pharmacists Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2021
• A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018
• Aerosolized Amikacin as Adjunctive Therapy of Ventilator-associated Pneumonia Caused by Multidrug-resistant Gram-negative Bacteria: A Single-center Randomized Controlled Trial Chinese medical journal, 2017
• A randomized, controlled study to investigate the efficacy and safety of a topical gentamicin-collagen sponge in combination with systemic antibiotic therapy in diabetic patients with a moderate or severe foot ulcer infection BMC infectious diseases, 2018
• Characterization of baseline polybacterial versus monobacterial infections in three randomized controlled bacterial conjunctivitis trials and microbial outcomes with besifloxacin ophthalmic suspension 0.6 PloS one, 2020
• Evaluation of a molecular point-of-care testing for viral and atypical pathogens on intravenous antibiotic duration in hospitalized adults with lower respiratory tract infection: a randomized clinical trial Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2019
• In Vitro Activity of Ceftazidime-Avibactam against Isolates from Respiratory and Blood Specimens from Patients with Nosocomial Pneumonia, Including Ventilator-Associated Pneumonia, in a Phase 3 Clinical Trial Antimicrobial agents and chemotherapy, 2020
• A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19) PloS one, 2020
• In Vitro Activity of Ceftazidime-Avibactam against Isolates from Patients in a Phase 3 Clinical Trial for Treatment of Complicated Intra-abdominal Infections Antimicrobial agents and chemotherapy, 2018
• Solithromycin in Children and Adolescents With Community-acquired Bacterial Pneumonia The Pediatric infectious disease journal, 2022
• A randomized phase-I pharmacokinetic trial comparing the potential biosimilar tocilizumab (QX003S) with the reference product (Actemra®) in Chinese healthy subjects Annals of medicine, 2021
• Analysis of Pooled Phase III Efficacy Data for Delafloxacin in Acute Bacterial Skin and Skin Structure Infections Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019
• Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients-a randomized clinical trial Critical care (London, England), 2020
• Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial Journal of hematology & oncology, 2021
• Pentoxifylline decreases serum LDH levels and increases lymphocyte count in COVID-19 patients: Results from an external pilot study International immunopharmacology, 2021
• Anti-bacterial antibodies in multiple myeloma patients at disease presentation, in response to therapy and in remission: implications for patient management Blood cancer journal, 2020
• Idasanutlin plus cytarabine in relapsed or refractory acute myeloid leukemia: results of the MIRROS trial Blood advances, 2022
• Vitamin D supplementation among Bangladeshi children under-five years of age hospitalised for severe pneumonia: A randomised placebo controlled trial PloS one, 2021
• Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units BMJ open, 2021
• Lefamulin vs moxifloxacin for community-acquired bacterial pneumonia Medicine, 2020
• Combination antibiotic therapy versus monotherapy in the treatment of acute exacerbations of chronic obstructive pulmonary disease: an open-label randomized trial BMC infectious diseases, 2021
• Randomized Double-Blind Phase II Trial of Fecal Microbiota Transplantation Versus Placebo in Allogeneic Hematopoietic Cell Transplantation and AML Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023
• The Effect of Melatonin on Thrombosis, Sepsis and Mortality Rate in COVID-19 Patients International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022
• Clinical efficacy of ulinastatin in the treatment of unliquefied pyogenic liver abscess complicated by septic shock: A randomized controlled trial Immunity, inflammation and disease, 2023
• Virgin coconut oil (VCO) supplementation relieves symptoms and inflammation among COVID-19 positive adults: a single-blind randomized trial Journal of nutritional science, 2024
• Safety and Efficacy of Ceftolozane/Tazobactam Plus Metronidazole Versus Meropenem From a Phase 2, Randomized Clinical Trial in Pediatric Participants With Complicated Intra-abdominal Infection The Pediatric infectious disease journal, 2023
• Long-acting granulocyte colony-stimulating factor in primary prophylaxis of early infection in patients with newly diagnosed multiple myeloma Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2022
• Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement Science translational medicine, 2023
• A randomized non-inferiority study comparing imipenem/cilastatin/relebactam with standard-of-care Gram-negative coverage in cancer patients with febrile neutropenia The Journal of antimicrobial chemotherapy, 2024
• Effectiveness of the modified TaWai mobile application for reporting adverse drug reaction in Lao PDR: a cluster randomized controlled trial Scientific reports, 2024
• Efficacy of empirical Ciprofloxacin or Cefixime plus Metronidazole therapy for the treatment of liver abscess: a randomized control clinical trial Scientific reports, 2024
• Multiplex real-time PCR in non-invasive respiratory samples to reduce antibiotic use in community-acquired pneumonia: a randomised trial Nature communications, 2024
• Clinical study on the treatment of Qingfei Paidu Granules combined with nondrug therapy for asymptomatic patients with novel coronavirus Medicine, 2024
• Etiology and efficacy of anti-microbial treatment for community-acquired pneumonia in adults requiring hospital admission in Ukraine Acta bio-medica : Atenei Parmensis, 2022
• Belantamab mafodotin, lenalidomide and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: part 1 results of a phase I/II study Haematologica, 2024
• Carbapenem-resistant Enterobacterales (CRE) acquisition and molecular characterization following colistin monotherapy and colistin-meropenem combination therapy: findings from the AIDA randomized trial Antimicrobial resistance and infection control, 2025
• DRTB-HDT: a randomized controlled trial of two adjunctive host-directed therapies in rifampin-resistant tuberculosis BMC infectious diseases, 2025
• Management of Ventilator-Associated Pneumonia Caused by Pseudomonas and Acinetobacter Organisms in a Pediatric Center: A Randomized Controlled Study Medicina (Kaunas, Lithuania), 2024
• An ex-vivo pharmacodynamic study comparing bactericidal activity of amoxicillin/sulbactam, azithromycin, doxycycline and levofloxacin against Streptococcus pneumoniae Journal of chemotherapy (Florence, Italy), 2004
• An open label, randomized comparative study of levofloxacin and amoxicillin/clavulanic acid in the treatment of purulent sinusitis in adult Thai patients Rhinology, 2004
• Outcome of treatment of respiratory tract infections due to Streptococcus pneumoniae, including drug-resistant strains, with pharmacokinetically enhanced amoxycillin/clavulanate International journal of antimicrobial agents, 2002
• Efficacy and safety of a novel, single-dose azithromycin microsphere formulation versus 10 days of levofloxacin for the treatment of acute bacterial sinusitis in adults Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2005
• A multicenter, randomized, double-blind, retrospective comparison of 5- and 10-day regimens of levofloxacin in a subgroup of patients aged > or =65 years with community-acquired pneumonia Clinical therapeutics, 2005
• Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study The Journal of antimicrobial chemotherapy, 1999
• A randomized, crossover design study of the pharmacology of extended-spectrum fluoroquinolones for pneumococcal infections Chest, 1999
• Predictors of symptom resolution in patients with community-acquired pneumonia Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000
• High-dose levofloxacin in community-acquired pneumonia: a randomized, open-label study Clinical drug investigation, 2012
• Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study BJOG : an international journal of obstetrics and gynaecology, 2010
• Efficacy of levofloxacin versus cefuroxime in treating acute exacerbations of chronic obstructive pulmonary disease International journal of chronic obstructive pulmonary disease, 2013
• Safety and efficacy of colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia as part of a macro-project funded by the Seventh Framework Program of the European Commission studying off-patent antibiotics: study protocol for a randomized controlled trial Trials, 2015
• Immunomodulatory effects of pidotimod in adults with community-acquired pneumonia undergoing standard antibiotic therapy Pulmonary pharmacology & therapeutics, 2017
• Low-dose trimethoprim-sulfamethoxazole treatment for Pneumocystis pneumonia: a systematic review and meta-analysis Frontiers in Pharmacology, 2024
• Intermittent Versus Daily Trimethoprim/Sulfamethoxazole Regimens for Pneumocystis Pneumonia Prophylaxis: A Systematic Review and Meta-analysis Open Forum Infectious Diseases, 2024
• Carbapenem vs. non-carbapenem antibiotics for ventilator-associated pneumonia: A systematic review with meta-analysis Respiratory Investigation, 2024
• Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis Canadian Medical Association Journal, 2020
• Association between various types of corticosteroids and mortality for severe community-acquired pneumonia in adults: a systematic review and network meta-analysis Frontiers in Pharmacology, 2024
• Tocilizumab in Patients with COVID-19 Pneumonia: A Systematic Review A Medical Research Archives, 2025
• Comments on “Efficacy and safety of adjunctive corticosteroids in the treatment of severe community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials” Critical Care, 2023
• Effect of perioperative oral care on postoperative pneumonia in thoracic surgery patients: a systematic review and meta-analysis Scientific Reports, 2025
• P-1163. The Efficacy and Safety of Tosufloxacin in the Treatment of Bacterial Infections in Children: Systematic Review Open Forum Infectious Diseases, 2025
• Effectiveness of Tocilizumab in COVID-19 Patients with Pneumonia: A Systematic Review Acta medica Philippina, 2025
• The Efficacy Of Respiratory Therapist-Led Protocols In Reducing Mechanical Ventilation Duration: A Systematic Review The Review of Diabetic Studies, 2025
• Pharyngeal Electrical Stimulation for Neurogenic Dysphagia: A Comprehensive Systematic Review of Efficacy, Safety, Cost-Effectiveness, and Implementation INDIAN JOURNAL OF PHYSICAL THERAPY, 2025
• Efficacy of higher-dose versus lower-dose corticosteroids in community-acquired pneumonia: a systematic review and network meta-analysis Critical Care, 2026
• The efficacy and safety of fiberoptic bronchoscopy-guided bronchial alveolar lavage combined with local drug injection in the treatment of severe pneumonia: a systematic review and meta-analysis based on randomized controlled trials Journal of Thoracic Disease, 2026
• Evidence for the Efficacy and Safety of Tigecycline for the Treatment of Ventilator-Associated Pneumonia in Preterm Infants: A Systematic Review Life, 2026
• Efficacy and safety of newer antibiotics versus generic antibiotics for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia: a systematic review and meta-analysis of randomized controlled trials medRxiv, 2026